Filters
Other countries
Results: 1 to 11 of 11
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
CAPN3 - NGS including CNV analysis Centogene US, LLC - The Rare Disease Company United States | 2 | 1 |
|
CAPN3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Rhabdomyolysis and Metabolic Myopathy Panel Invitae United States | 202 | 128 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 480 | 254 |
|
Invitae Comprehensive Muscular Dystrophy Panel Invitae United States | 114 | 52 |
|
Invitae Limb-Girdle Muscular Dystrophy Panel Invitae United States | 91 | 37 |
|
Invitae Comprehensive Neuromuscular Disorders Panel Invitae United States | 353 | 208 |
|
CAPN3 Full Gene Sequencing Analysis + MLPA Duplication/Deletion Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 2 | 1 |
|
CAPN3 MLPA Duplication/Deletion Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 2 | 1 |
|
CAPN3 Full Gene Sequencing Analysis MNG Laboratories (Medical Neurogenetics, LLC.) United States | 2 | 1 |
|
Muscular dystrophy, limb-girdle, autosomal dominant: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 5 | 7 |
|
Results: 1 to 11 of 11
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.